Literature DB >> 1202955

Serosurvey for "acute hemorrhagic conjunctivitis" virus (Enterovirus 70) antibodies in the Southeastern United States, with review of the literature and some epidemiologic implications.

J C Hierholzer, K A Hilliard, J J Esposito.   

Abstract

Acute hemorrhagic conjunctivitis (AHC) has been epidemic throughout much of the Eastern Hemisphere since its emergence in central West Africa in 1969. The disease had a distinctive clinical picture and an unusual geographic epidemiology. Between 1969 and 1975 AHC has occurred almost exclusively in crowded coastal areas of tropical countries during hot, rainy seasons. Only a few documented outbreaks have occurred in inland cities and in subtropical or temperate climate zones. Of 1014 residents of the eastern or southeastern United States who were screende for neutralizing antibodies to three or four strains of AHC virus (enterovirus type 70), three (0.3%) had titers ranging from 1:10 to 1:40. However, no clinical evidence of prior experience with AHC disease could be ascertained for these persons, so that the antigenic specificity of the detected antibodies is unknown. We conclude that populations of coastal tropical areas of northern South America and all of Central America are vulnerable to AHC epidemics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1202955     DOI: 10.1093/oxfordjournals.aje.a112191

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

1.  Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses.

Authors:  G J Stanton; M P Langford; S Baron
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells.

Authors:  Nitesh Mistry; Hirotoshi Inoue; Fariba Jamshidi; Rickard J Storm; M Steven Oberste; Niklas Arnberg
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  SCH 48973: a potent, broad-spectrum, antienterovirus compound.

Authors:  P J Buontempo; S Cox; J Wright-Minogue; J L DeMartino; A M Skelton; E Ferrari; R Albin; E J Rozhon; V Girijavallabhan; J F Modlin; J F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 4.  Enteroviral conjunctivitis and its neurological complications.

Authors:  P G Higgins
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  Enterovirus type 70 virion and intracellular proteins.

Authors:  J J Esposito; J F Obljeski
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

6.  Detection of enterovirus 70 with monoclonal antibodies.

Authors:  L J Anderson; M H Hatch; M R Flemister; G E Marchetti
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

7.  Oligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: evidence for a close genetic relationship among Asian and American strains.

Authors:  O M Kew; B K Nottay; M H Hatch; J C Hierholzer; J F Obijeski
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  The investigation of a recurrence of an AHC virus epidemic at Lucknow: a serosurvey for AHC virus antibodies before and after the epidemic.

Authors:  A Mathur; B Sharma; U C Chaturvedi
Journal:  J Hyg (Lond)       Date:  1977-10

9.  Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains.

Authors:  J C Hierholzer; P G Bingham; R A Coombs; Y O Stone; M H Hatch
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.